The Analysis of Oramed Pharmaceuticals Inc.'s Holdings & P&L

Currently, Oramed Pharmaceuticals Inc. holds 3 types of securities in its portfolio with a total value $36.2M. In the most recent quarter, they have increased their positions in SCLX (+437.5K shares, valued at $3.6M), NNDM (+528.4K shares, valued at $988.0K); decreased their positions in LFWD (-8.2M shares, valued at $54.1M); initiated new positions in SCLX (+437.5K shares, valued at $3.6M).

1M P&L

+1.7M+8.21%

3M P&L

-1.7M-7.15%

HY P&L

-3.2M-12.56%

P&L figures are estimated based on reported 13F stock holdings and market price changes. They are approximations and may not reflect actual fund performance. Stock split events may also affect the accuracy of these calculations, and we cannot guarantee that all splits have been fully accounted for.

Top Holding Treemap

Top Industries by Value

1Computer Hardware22.3M

86.0%

2Drug Manufacturers - General3.6M

14.0%

Top Industries by Stock Count

1Drug Manufacturers - General1 stocks

50.0%

2Computer Hardware1 stocks

50.0%

Sponsored

Stock Holdings

TickerCompany NameSharesShares △%Event DateReport DateHistory

NNDM 10.9M shares5.07%2026-02-172026-02-19

LFWD 6.9M shares-54.38%2026-07-202026-07-22

SCLX 437.5K sharesnew addition2025-12-312026-02-13

NNDM

5.07%

Shares10.9M

Event2026-02-17

Filed2026-02-19

LFWD

-54.38%

Shares6.9M

Event2026-07-20

Filed2026-07-22

SCLX

New

Shares437.5K

Event2025-12-31

Filed2026-02-13

Call Option Holdings

No call option holdings data available

Put Option Holdings

No put option holdings data available